esomeprazole sold brand name nexium neksium among medication reduces stomach used treat gastroesophageal reflux disease peptic ulcer disease effectiveness similar proton pump inhibitors taken mouth injection common side effects include headache constipation dry mouth abdominal serious side effects may include angioedema clostridium difficile infection use pregnancy appears safe safety breastfeeding esomeprazole works blocking hkatpase parietal cells patented approved medical use available generic medication sold counter number commonly prescribed medication united states million also available lower dose formulations without prescription united united well australia canada new primary uses esomeprazole gastroesophageal reflux disease treatment maintenance erosive esophagitis treatment duodenal ulcers caused h pylori prevention gastric ulcers chronic nsaid therapy treatment gastrointestinal ulcers associated crohns gastroesophageal reflux disease gerd condition digestive acid stomach comes contact esophagus irritation caused disorder known longterm contact gastric acids esophagus cause permanent damage esophagus associated barretts esomeprazole reduces production digestive acids thus reducing effect esophagus esomeprazole combined antibiotics clarithromycin amoxicillin metronidazole instead amoxicillin penicillinhypersensitive patients eradication triple therapy helicobacter pylori infection h pylori causative factor majority peptic duodenal ulcers meta analysis concluded compared proton pump inhibitors esomeprazole confers modest overall benefit esophageal healing symptom relief broken disease severity benefit esomeprazole relative proton pump inhibitors negligible people mild disease number needed treat needed appeared severe disease number needed treat second meta analysis also found increases erosive esophageal healing healing rate compared standardized doses broadly selected patient study found esomeprazole among number effective common side effects include headache diarrhea nausea flatulence decreased appetite constipation dry mouth abdominal pain severe side effects severe allergic reactions chest pain dark urine fast heartbeat fever paresthesia persistent sore throat severe stomach pain unusual bruising bleeding unusual tiredness yellowing eyes proton pump inhibitors may associated greater risk hip clostridium difficileassociated patients frequently administered drugs intensive care protective measure ulcers use also associated increase occurrence longterm use proton pump inhibitors patients treated helicobacter pylori shown dramatically increase risk gastric acute tubulointerstitial nephritis possible adverse reaction using proton pump esomeprazole competitive inhibitor enzyme may therefore interact drugs depend metabolism diazepam warfarin concentrations drugs may increase used concomitantly conversely clopidogrel plavix inactive prodrug partially depends conversion active form inhibition blocks activation clopidogrel thus reducing drugs depend stomach ph absorption may interact esomeprazole drugs depend acidic environment ketoconazole atazanavir poorly absorbed whereas drugs broken acidic environments erythromycin absorbed greater extent single mg oral doses generally give rise peak plasma esomeprazole concentrations mgl within hours several days oncedaily administration levels may increase intravenous infusion similar dose usually produces peak plasma levels order mgl drug rapidly cleared body largely urinary excretion pharmacologically inactive metabolites esomeprazole metabolites analytically indistinguishable omeprazole corresponding omeprazole metabolites unless chiral techniques esomeprazole available delayedrelease capsules united states delayedrelease tablets australia united kingdom canada containing esomeprazole magnesium strengths mg delayedrelease capsules united states containing esomeprazole strontium mg strength delivering equivalent mg esomeprazole sodium intravenous injectioninfusion oral esomeprazole preparations entericcoated due rapid degradation drug acidic conditions stomach achieved formulating capsules using multipleunit pellet system combination naproxenesomeprazole magnesium brand name vimovo used prevention gastric ulcers associated chronic nsaid therapy vimovo available two dosage strengths mg mg clinical trials naproxenesomeprazole demonstrated incidence gi ulcer patients naproxen alone versus fda added warnings label vimovo concerning acute interstitial nephritis risk kidney problems esomeprazole capsules well losecprilosec tablets formulated multipleunit pellet system mups essentially capsule consists extremely small entericcoated granules pellets esomeprazole formulation inside outer shell capsule immersed aqueous solution happens capsule reaches stomach water enters capsule osmosis contents swell water absorption causing shell burst releasing entericcoated granules patients multipleunit pellet system advantage conventional entericcoated preparations patients formulation benefit include requiring nasogastric tube feeding difficulty swallowing astrazeneca announced copromotion agreement daiichi sankyo distribute nexium september nexium approved sale launched daiichi sankyo esomeprazole approved use united states february launch esomeprazole drug netted astrazeneca controversy astrazenecas behaviour creating patenting marketing drug esomeprazoles successful predecessor omeprazole mixture two mirrorimaged molecules esomeprazole senantiomer romeprazole critics said company trying evergreen omeprazole patent patenting pure esomeprazole aggressively marketing doctors effective generic versions esomeprazole magnesium available available overthecounter brand name nexium united injection formulations esomeprazole used gastroprotection veterinary medicine goats administered drug intravenous subcutaneous injection rapid elimination noted study sulfone metabolite detectable several hours injection parent drug esomeprazole used gokmen et al screen efficacy trichomonas vaginalis isolates found esomeprazole effective veterinary httpsenwikipediaorgwikiesomeprazole